Improved survival rate and quality of life
The first version of the ARNE device was successfully used in a clinical study focused on Newborn Life Support (NLS). The results clearly demonstrated a reduction in error rates and missed steps during neonatal resuscitation. With ARNE, resuscitation procedures are not only faster, but also more accurate and timely, ensuring that critical interventions are delivered when they matter most.
These improvements strongly suggest that survival rates will increase, and just as importantly, the quality of survival is expected to improve as well.
This has significant long-term implications—not only for the infants and families directly affected, but also for the healthcare system and society as a whole. Many infants who survive with severe neurological or physical impairments require lifelong, costly care. By improving the quality of resuscitation at birth, ARNE contributes to better neurodevelopmental outcomes and helps reduce the long-term societal and economic burden.
More information can be read hereImproving adherence to NLS Guidelines
The European Resuscitation Council (ERC) and the American Heart Association (AHA) have established evidence-based guidelines to standardize neonatal resuscitation and transition care after birth. However, the critical question remains: How closely do delivery room teams follow these protocols in real-world practice?
Research and clinical observations show that guideline adherence is still far from optimal, especially during complex or high-stress scenarios—highlighting a clear need for improvement.
The ARNE NLS Advisor directly addresses this challenge by introducing the first-ever clinical decision support device specifically designed for Newborn Life Support (NLS) procedures. By guiding care teams in real time, ARNE supports accurate, consistent execution of resuscitation steps, helping to close the gap between guidelines and practice.
More information can be read hereImproving NLS Guideline Adherence with Clinical Decision Support
What impact does a Clinical Decision Support System (CDSS) have on adherence to the Neonatal Resuscitation Program (NRP) algorithm?
A randomized controlled trial provides a clear answer:
‘Healthcare professionals using a decision support tool demonstrate significantly fewer deviations from the Neonatal Resuscitation Program algorithm compared to those relying on memory alone during simulated neonatal resuscitation’.*
These findings highlight the value of integrating decision support into delivery room workflows. By reducing reliance on memory and providing real-time, step-by-step guidance, a CDSS like the ARNE NLS Advisor enhances performance, consistency, and adherence, ultimately contributing to better outcomes in newborn resuscitation.
*Janene H Fuerch et al. – Resuscitation, March 2015.
Discover how ARNE can improve Neonatal Care?
Contact us to learn how our solution can support your team and improve outcomes.